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Introduction {#sec005}
============

Excessive adiposity is a risk factor for cardiovascular diseases and type 2 diabetes mellitus. Prospective studies have shown that obese and overweight individuals \[[@pone.0194644.ref001]--[@pone.0194644.ref003]\] as well as those with excessive abdominal fat \[[@pone.0194644.ref004]--[@pone.0194644.ref006]\], have increased risk for cardiovascular diseases and death, indicating a possible causative role of excessive abdominal adiposity in these conditions \[[@pone.0194644.ref007]\].

Numerous methodologies to study body composition and adipose tissue distribution are currently available; however, many of them cannot be used in usual clinical settings. For that reason, anthropometric approaches that require few resources and have acceptable correlation with reference techniques have been developed \[[@pone.0194644.ref008]\].

Expert groups have recommended waist circumference (WC) as an anthropometric approximation for intra-abdominal fat content. In fact, WC has a good direct correlation with more direct methods for quantifying body composition and is a technically and economically accessible procedure in a variety of clinical scenarios, including those in developing countries or rural clinics \[[@pone.0194644.ref008], [@pone.0194644.ref009]\].

The World Health Organization (WHO) \[[@pone.0194644.ref010]\], American Association of Endocrinology (AAE), and US National Program for Cholesterol Education (NCEP ATP III) \[[@pone.0194644.ref011]\] proposed to define AO with mean WC of adults with a body mass index (BMI) of 30 kg/m^2^. Therefore, WC cutoffs defined by these organizations were 88 cm for women and 102 cm for men. By contrast, the International Diabetes Federation (IDF) proposed to use average WC of subjects with a BMI of 25 kg/m^2^ and recognized that ethnical differences must be considered to define correlation between AO and metabolic syndrome risk factors \[[@pone.0194644.ref012]\]. Consequently, IDF did not make specific cutoff recommendations for Hispanic ethnicity but suggested to use values of South Asian population (80 cm for women and 90 cm for men).

Herein we aimed to determine the predictive capability of WC for cardiovascular risk factors (CVRF) and estimate optimal WC cutoff values for the hispanic population of Chile. We evaluated the association between abdominal obesity and CVRF and diseases in non-obese individuals.

Subjects and methods {#sec006}
====================

1. General design and measurements {#sec007}
----------------------------------

This cross-sectional study was a secondary analysis of the National Health Survey of Chile (ENS) 2009--2010. General methodology of ENS is detailed elsewhere \[[@pone.0194644.ref013]\].

Participants were evaluated by research nurses who determined arterial blood pressure and anthropometric parameters. Blood aliquots were drawn to determine fasting glycemia, total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol and triglycerides.

Trained interviewers collected data on demographics and physician-diagnosed cardiovascular diseases (myocardial infarction and stroke) as well as other medical conditions not considered.

Height and weight were measured using stadiometers and digital scales. BMI was calculated by the regular formula (weight \[kg\]/height \[m^2^\]. WC was quantified in the mid axillary line at the midpoint between the lower costal ridge and the upper margin of superior iliac crest, using a flexible plastic tape that was replaced after 80 determinations.

Systolic and diastolic arterial blood pressure was determined with an automated device (OMRON-HEM 713 C). These determinations were performed in the morning after overnight fasting and bladder emptying and 5 minutes of rest in a chair. Two separate measurements were taken for 2 minutes and average of both values was used for analysis.

2. Definition of the variables {#sec008}
------------------------------

1.  BMI categories: categories of normal weight, overweight and obese were defined according to BMI ranges of 18.5--24.9 kg/m^2^, 25--29.9 kg/m^2^ and 30--39.9 kg/m^2^, respectively.

2.  Systolic hypertension: systolic arterial pressure ≥ 140 mmHg or self-report.

3.  Diastolic hypertension: diastolic arterial pressure ≥ 90 mmHg or self-report.

4.  Total hypercholesterolemia: total cholesterol (total-C) ≥ 200 mg/dl.

5.  LDL hypercholesterolemia: LDL cholesterol (LDL-C) ≥ 130 mg/dl.

6.  Decreased HDL cholesterol: HDL cholesterol (HDL-C) ≤ 40 mg/dl in men or ≤ 50 mg/dl in women.

7.  Hypertriglyceridemia: triglycerides ≥ 150 mg/dl.

8.  Impaired fasting glucose: fasting blood glucose between 100 and 125 mg/dl.

9.  Diabetes mellitus: fasting blood glucose ≥ 126 mg/dl or self-report.

10. CVRF: WHO guidelines establish that development of WC cutoff points should identify at least one of the three following risk factors: high blood pressure, elevated cholesterol or elevated blood glucose \[[@pone.0194644.ref014]\]. Our model identifies at least one of the following risk factors: systolic or diastolic hypertension, total hypercholesterolemia, LDL hypercholesterolemia, decreased HDL-C hypertriglyceridemia, diabetes mellitus or impaired fasting glucose.

11. Abdominal obesity (AO): in this work, we used two set of values determined as indicated in the following section. For all BMI ranges, WC cutoffs for AO definition were ≥ 88 cm in women and ≥ 93 cm in men. For individuals with BMI in normal and overweight range, WC cutoffs were ≥ 83 cm in women and ≥ 91 cm in men.

3. Statistical analysis {#sec009}
-----------------------

A total of 5293 subjects of both sexes and older than 15 years of age composed the total sample of the ENS 2009--2010. In the ENS 2009--2010 some determinations were not complete for individual subjects. These omissions are randomly distributed across the studied groups and thus in some tables the totals do not correspond to the simple sum of individual groups. Subjects with mistaken or rejected measurement of waist circumference were excluded from analysis, leaving a final sample of 5248 subjects.

Expansion factors specifically designed for this survey were used to give each participant the weight that corresponds according to the complex sample design and to correct the distortion of the raw sample, making it coincident with the census population projection to January 2010 for Chilean adults over 15 years of age. A detailed mathematical method for this procedure was published elsewhere \[[@pone.0194644.ref013]\].

Confounding factors for the association between WC and CVRF were determined by logistic regression analysis.

A predictive model was generated using the dependent variable CVRF and the independent variable WC for each sex. Predictive accuracy of WC was evaluated by area under curve of receiver operating characteristic (AUC-ROC) analysis \[[@pone.0194644.ref015]\]. Calibration of the model was determined using the Hosmer-Lemeshow goodness-of-fit test and was considered adequate with p \> 0.05, indicating that the observed probability of having cardiovascular risk factors do not significantly differ from the probability predicted by the model \[[@pone.0194644.ref016]\]. Youden Index was calculated (highest sensitivity + specificity---1) to identify the best cutoff value based on the largest vertical distance between the ROC curve and the diagonal curve (or maximal value).

Categorical variables are presented as frequency according to individual estimated sample of each variable and percentage; their association with AO was analyzed with the independent χ^2^ statistic in a contingency model of exposure or non-exposure. Fisher´s exact test was used when the expected frequency was below 5. Differences were considered significant with a p value \<0.05. Numerical variables are presented as mean and confidence intervals.

Scatter plots were generated to analyze the relationship between WC and BMI in both sexes. Spearman correlation was used to determine the association between these variables.

Stata SE software (version 13, College Station, Texas, USA) was used for statistical analysis and graphs.

Results {#sec010}
=======

To study cardiometabolic impact of AO we analyzed the latest National Health Survey of Chile (ENS 2009--2010). [Table 1](#pone.0194644.t001){ref-type="table"} shows the sample characteristics. In total, 5248 persons aged 15 years or older were included in the present analysis. Mean age was 40.5 years and 42.3 years in men and women, respectively. Overweight was the most frequent BMI category in both sexes. About one third of men and one fourth of women had hypertension. The most frequent CVRF was total hypercholesterolemia. Diabetes Mellitus was present with more frequency in women and stroke with more frequency in men.

10.1371/journal.pone.0194644.t001

###### General characteristics of the sample.

![](pone.0194644.t001){#pone.0194644.t001g}

                                       Men   Women         
  ------------------------------------ ----- ------- ----- -------
  Normal weight (18.5--24.9 kg/m^2^)   645   34.42   938   33.41
  Overweight (25--29.9 kg/m^2^)        851   45.17   942   33.56
  Obese (30--39.9 kg/m^2^)             341   18.07   771   27.47
  [**Conditions**]{.ul}                                    
  Systolic hypertension                400   21.15   477   16.92
  Diastolic hypertension               273   14.50   195   6.92
  Total hypercholesterolemia           430   38.99   601   38.09
  LDL hypercholesterolemia             335   30.56   473   30.00
  Decreased HDL-C                      459   24.14   913   32.17
  Hypertriglyceridemia                 397   35.97   429   27.17
  Impaired fasting glucose             235   12.38   288   10.13
  Diabetes Mellitus                    146   7.91    260   9.51
  AMI                                  64    3.37    87    3.06
  Stroke                               48    2.54    50    1.76

Number of observations were calculated based on percentages and total observations for each variable in survey data. CI: confidence interval. HDL-C-: concentration of cholesterol in high-density lipoproteins; AMI: acute myocardial infarction.

To assess the role of WC as an independent predictor of cardiovascular risk, we first performed logistic regression for confounding factors in the whole sample, i.e., including individuals of all the BMI ranges and both sexes. We found that age, height, educational level, physical activity, smoking status and alcohol did not influence the relationship between WC and CVRF. In this global analysis of the sample, the mean BMI was 27.2 kg/m^2^.

Next, we generated a model for CVRF prediction using WC as an independent variable in the whole sample. AUC-ROC value was 0.70 for men ([Fig 1A](#pone.0194644.g001){ref-type="fig"}) and 0.67 for woman ([Fig 1B](#pone.0194644.g001){ref-type="fig"}). These models showed good fitness as indicated by Hosmer-Lemeshow values of 15.32 (p = 0.0533) and 13.84 (p = 0.0860) for men and women, respectively. To determine the WC cutoff value for the definition of AO, we used Youden index analysis. In men, a WC cutoff value of 93 cm had Youden index of 0.31 for CVRF prediction and 64.9% sensibility, 66% specificity, and 65.2% of correctly classified subjects. In women, a WC cutoff value of 88 cm had a Youden index of 0.25 and 64.08% sensibility, 60.63% specificity, and 62.84% of correctly classified subjects.

![ROC analysis for WC and CVRF in the whole sample defined by the presence of at least one of the following risk factors: Systolic or diastolic hypertension, total hypercholesterolemia, LDL hypercholesterolemia, decreased HDL-C hypertriglyceridemia, impaired fasting glucose or diabetes mellitus in men (A) and women (B).](pone.0194644.g001){#pone.0194644.g001}

Using 93 cm and 88 cm as cutoff values for AO in men and women, respectively, we analyzed the relationships between AO and the frequency of cardiometabolic risk factors in overweight and normal weight individuals. As shown in [Table 2](#pone.0194644.t002){ref-type="table"}, AO was associated with increased frequency of systolic and diastolic hypertension, total and LDL hypercholesterolemia, Impaired fasting glucose and diabetes mellitus in overweight men. In overweight women, AO was associated with systolic hypertension, hypertriglyceridemia, impaired fasting glucose and diabetes mellitus. In both sexes, AO was associated with increased frequency of stroke.

10.1371/journal.pone.0194644.t002

###### Frequency of CVRF, AMI and stroke in overweight individuals (BMI: 25--29.99 kg/m^2^) with AO.

![](pone.0194644.t002){#pone.0194644.t002g}

                               Men (n = 851)   Women (n = 942)                                                        
  ---------------------------- --------------- ----------------- ----- ------- ---------- ----- ------- ----- ------- ----------
  Number of cases              321             37.7              530   62.3               394   41.8    548   58.2    
  Systolic hypertension        24              7.64              148   27.93   \<0.0001   36    8.44    128   21.63   \<0.0001
  Diastolic hypertension       34              10.51             92    17.39   0.016      25    5.79    41    6.97    0.109
  Total hypercholesterolemia   60              34.24             155   50.64   0.026      79    33.85   135   44.31   0.096
  LDL hypercholesterolemia     49              28.53             128   41.99   0.044      54    23.47   123   40.49   0.125
  Decreased HDL-C              49              15.36             127   23.61   0.083      134   31.43   166   28.03   0.821
  Hypertriglyceridemia         57              32.64             120   38.96   0.061      39    16.71   85    27.77   0.015
  Impaired fasting glucose     17              5.17              88    16.45   \<0.0001   22    5.09    89    15.05   \<0.0001
  Diabetes Mellitus            12              3.63              46    8.97    0.001      12    2.94    83    14.47   \<0.001
  AMI                          8               2.57              18    3.36    0.307      11    2.59    19    3.28    0.222
  Stroke                       2               0.73              25    4.72    0.019      6     1.38    17    2.95    0.001

AO: Abdominal obesity defined by WC cutoff of 93 cm in men and 88 cm in women. Other abbreviations as in [Table 1](#pone.0194644.t001){ref-type="table"}.

The implications of AO on cardiometabolic health of normal weight individuals are shown in [Table 3](#pone.0194644.t003){ref-type="table"}. In normal weight men, the association between AO and CVRF and disease was even higher than in overweight subjects, since the frequency of AMI and stroke as well as all CVRF analyzed (8 over 8) were increased. By contrast, in normal weight women, AO was associated with an increased frequency of only 3 over 8 CVRF (total hypercholesterolemia, hypertriglyceridemia and impaired fasting glucose) and AMI.

10.1371/journal.pone.0194644.t003

###### Frequency of CVRF, AMI and stroke in normal weight individuals (BMI:18.5--24.99 kg/m^2^) with AO.

![](pone.0194644.t003){#pone.0194644.t003g}

                               Men (n = 645)   Women (n = 938)                                                       
  ---------------------------- --------------- ----------------- ---- ------- ----------- ----- ------- ---- ------- -------
  Number of cases              584             90.5              61   9.5                 873   93.1    65   6.9     
  Systolic hypertension        59              11.59             10   19.89   \< 0.0001   76    10.18   12   23.54   0.113
  Diastolic hypertension       28              5.47              12   22.81   \< 0.0001   21    2.77    2    3.03    0.06
  Total hypercholesterolemia   67              22.33             24   79      0.034       108   25.11   20   56.24   0.002
  LDL hypercholesterolemia     47              15.41             24   78.46   0.024       83    19.37   14   38.35   0.22
  Decreased HDL-C              85              16.71             35   67.01   \< 0.0001   191   25.55   5    10.02   0.769
  Hypertriglyceridemia         48              15.99             18   57.51   \<0.0001    46    10.57   8    22.29   0.001
  Impaired fasting glucose     39              7.58              7    13.06   \<0.0001    25    3.39    3    5.83    0.001
  Diabetes Mellitus            17              3.37              10   20.39   \<0.0001    31    4.23    3    5.72    0.299
  AMI                          5               1.07              2    3.86    0.007       15    1.97    2    2.85    0.04
  Stroke                       2               0.32              1    0.13    0.01        5     0.61    0    0       0.515

AO: Abdominal obesity defined by WC cutoff of 93 cm in men and 88 cm in women. Other Abbreviations as in [Table 1](#pone.0194644.t001){ref-type="table"}.

Because of the lower number of associations between WC and CVRF in normal weight versus overweight women, we decided to investigate whether the cause of this apparent lower discriminative power was an inadequate WC cutoff point for this subgroup of individuals. For this purpose, we performed a new ROC analysis that exclusively included normal and overweight subsample in both sexes. In this new analysis, the mean BMI was 25.1 kg/m^2^.

As shown in [Fig 2](#pone.0194644.g002){ref-type="fig"}, AUC-ROC for normal weight and overweight subjects was 0.66 and 0.63, for men and woman, respectively. These models also showed good fitness as indicated by Hosmer-Lemeshow values of 11.18 (p = 0.1919) and 9.93 (p = 0.2696) for men and women, respectively. We found that in normal and overweight men a WC cutoff value of 91 cm had a Youden index of 0.26 for CVRF prediction and 60.66% sensibility, 65.11% specificity, and 62.43% of correctly classified subjects. In normal and overweight women, a WC cutoff value of 83 cm had Youden index of 0.19 and 63.02% sensibility, 55.99% specificity, and 60.01% of correctly classified subjects.

![ROC analysis for WC and CVRF in normal and overweight subsample defined by the presence of at least one of the following risk factors: Systolic or diastolic hypertension, total hypercholesterolemia, LDL hypercholesterolemia, decreased HDL-C hypertriglyceridemia, impaired fasting glucose or diabetes mellitus in men (A) and women (B).](pone.0194644.g002){#pone.0194644.g002}

With these new WC cutoff values (91 cm in men and 83 cm in women) we re-evaluated the association between AO and the frequency of CRVF in overweight and normal weight individuals, excluding underweight and obese subjects. As shown in [Table 4](#pone.0194644.t004){ref-type="table"}, AO was associated with equivalent increased frequency of CVRF in overweight men and women (compare with [Table 2](#pone.0194644.t002){ref-type="table"}).

10.1371/journal.pone.0194644.t004

###### Frequency of CVRF, AMI and stroke in overweight individuals (BMI: 25--29.99 kg/m^2^) with AO defined by lower WC cutoff values.

![](pone.0194644.t004){#pone.0194644.t004g}

                               Men (n = 851)   Women (n = 942)                                                        
  ---------------------------- --------------- ----------------- ----- ------- ---------- ----- ------- ----- ------- ----------
  Number of cases              221             26                630   74                 166   17.6    776   82.4    
  Systolic hypertension        15              6.85              156   24.73   \<0.0001   8     4.55    153   18.38   \<0.0001
  Diastolic hypertension       11              5.07              117   18.52   0.019      7     4.02    59    7.11    0.777
  Total hypercholesterolemia   39              33.65             174   47.89   0.014      39    36.66   173   40.14   0.544
  LDL hypercholesterolemia     30              25.82             149   41.06   0.002      22    20.41   156   36.26   0.169
  Decreased HDL-C              35              15.75             139   21.75   0.298      60    33.47   240   28.63   0.636
  Hypertriglyceridemia         36              30.83             139   38.26   0.16       16    15.31   107   24.8    0.016
  Impaired fasting glucose     13              5.96              91    14.18   0.01       9     4.93    96    11.54   0.015
  Diabetes Mellitus            7               3.07              26    8.26    0.003      6     3.33    84    10.44   0.009
  AMI                          6               2.57              21    3.23    0.321      4     2.34    26    3.13    0.271
  Stroke                       1               0.61              26    4.08    0.015      3     0.19    18    2.18    0.193

AO: Abdominal obesity defined by WC cutoff of 91 cm in men and 83 cm in women. Other abbreviations as in [Table 1](#pone.0194644.t001){ref-type="table"}.

In normal weight men, AO continued to be associated with increased frequency of all CVRF (8 over 8), AMI and stroke ([Table 5](#pone.0194644.t005){ref-type="table"}, compare with [Table 3](#pone.0194644.t003){ref-type="table"}). Interestingly, the new WC cutoff value for non-obese women (83 cm instead of 88 cm), determined a higher frequency of CVRF (6 over 8: systolic and diastolic hypertension, total and LDL hypercholesterolemia, hypertriglyceridemia and impaired fasting glucose) and AMI in normal weight women ([Table 5](#pone.0194644.t005){ref-type="table"}, compare with [Table 3](#pone.0194644.t003){ref-type="table"}). These results suggest that lower WC cutoff values are required to correctly classify AO in normal weight women, in terms of their CVFR and disease frequency.

10.1371/journal.pone.0194644.t005

###### Frequency of CVRF, AMI and stroke in normal weight individuals (BMI:18.5--24.99 kg/m^2^) with AO defined by lower WC cutoff values.

![](pone.0194644.t005){#pone.0194644.t005g}

                               Men (n = 645)   Women (n = 938)                                                        
  ---------------------------- --------------- ----------------- ---- ------- ----------- ----- ------- ----- ------- ----------
  Number of cases              557             86.3              88   13.7                747   79.6    191   20.4    
  Systolic hypertension        53              10.9              17   23.57   \< 0.0001   45    7.08    50    30.9    \<0.0001
  Diastolic hypertension       27              5.48              15   20.22   \< 0.0001   16    2.42    7     4.63    0.014
  Total hypercholesterolemia   63              21.69             32   73.73   0.005       92    24.67   40    41.72   \<0.0001
  LDL hypercholesterolemia     43              14.8              32   72.08   0.003       71    19.15   28    29.22   0.006
  Decreased HDL-C              80              16.39             46   61.85   \< 0.0001   171   26.66   23    14.19   0.683
  Hypertriglyceridemia         46              16.04             22   50.81   \<0.0001    32    8.73    25    26.75   0.001
  Impaired fasting glucose     36              7.38              10   13.62   \<0.0001    17    2.72    12    7.7     \<0.0001
  Diabetes Mellitus            15              3.19              13   19.41   \<0.0001    21    3.37    14    9.07    0.062
  AMI                          5               0.97              3    4.19    0.003       3     0.47    16    10      0.004
  Stroke                       2               0.32              1    1.24    0.006       4     0.61    1     0.36    0.665

AO: Abdominal obesity defined by WC cutoff of 91 cm in men and 83 cm in women. Other abbreviations as in [Table 1](#pone.0194644.t001){ref-type="table"}.

Lastly, we analyzed the relationship between BMI and WC; and the frequency of AO in normal and overweight population defined by the WC cutoff points found herein (91 and 83 cm for men and women, respectively) ([Fig 3](#pone.0194644.g003){ref-type="fig"}). As expected, WC was directly correlated with BMI in both sexes (men, r = 0.86, p \<0.00001; women, r = 0.87, p \<0.00001) and virtually all obese individuals had AO (98.2% and 99.1%, men and women, respectively). Notably, a high proportion of overweight and normal weight subjects also presented AO (70.5%/77.4%, and 12.4%/16.4% of overweight and normal weight men and women, respectively, had AO). Since almost all obese subjects had AO, these results indicate that the clinical emphasis of excessive WC, and thus intra-abdominal adiposity, on cardiovascular health must be focused in normal and overweight non-obese individuals.

![Correlation between BMI and WC in adults from ENS-Chile 2009--2010.\
Anthropometric values were measured in a total of 2132 men (A) and 3116 women (B). Vertical lines indicate the BMI values defining normal weight (18.5--24.9 kg/m^2^), overweight (25--29.9 kg/m^2^) and obesity (≥ 30 kg/m^2^). Horizontal lines indicate the WC cutoff defining AO in men (91 cm) and women (83 cm).](pone.0194644.g003){#pone.0194644.g003}

Discussion {#sec011}
==========

Obesity is recognized as a major cardiovascular risk factor. The World Health Organization and the US National Institutes of Health (NIH) have proposed, based on prospective mortality studies, to use BMI as the \"indicator\" to estimate the cardio-metabolic risk magnitude. In fact, BMI levels ≥ 30 kg/m^2^ define the diagnosis of obesity, which is associated with the highest cardio-metabolic risk compared to other BMI categories \[[@pone.0194644.ref010]\]. Nonetheless, elevated WC further increases the cardio-metabolic risk determined by elevated BMI \[[@pone.0194644.ref017]--[@pone.0194644.ref019]\]. Therefore, some guidelines consider WC as a risk estimator with added value to the BMI \[[@pone.0194644.ref020], [@pone.0194644.ref021]\].

Concordantly, whereas some multivariate models have found that global adiposity assessed by the BMI is not associated with CVD risk, indicators of visceral adiposity, such as WC and waist to hip ratio (WHR), are directly associated with increased risk of CVD and all-cause mortality \[[@pone.0194644.ref022]\].We chose to use WC instead of WHR because the latter is not able to reliably predict the absolute amount of visceral adipose tissue that is also related to total adiposity \[[@pone.0194644.ref023]\]; and instead of waist to height ratio because no formal cutoff values have been established by international clinical guidelines for adults yet, in spite of the increasing studies emphasizing its clinical utility and diagnostic accuracy \[[@pone.0194644.ref024]\].

Our results support that WC behaves as an independent and statistically acceptable discriminator of CVRF frequency in the Hispanic population of Chile. ROC analysis of the whole sample, including all BMI ranges, showed an estimated predictability of 0.70 in men and 0.67 in woman, for identifying at least one cardiovascular risk factor. Our results are similar to others previously reported for the Chilean population \[[@pone.0194644.ref025]\]

Our study showed that in non-obese men, WC cutoffs for AO based on AUC-ROC analysis with either all categories of BMI (93 cm) or restricted to normal and overweight subjects (91 cm), was strongly associated with increased frequency of most or all CVRF and diseases in overweight and normal weight individuals.

In contrast, we noted that the frequency of CVRF in non-obese women was significantly different with the two different AO definitions reported herein. When AO was defined by AUC-ROC analysis based on the whole sample (88 cm), normal weight women had 3 over 8 CVRF; whereas, when AO was defined by AUC-ROC analysis of non-obese women exclusively (83 cm) they had 6 over 8 CVRF. This suggests that the cutoff point established by the whole sample may be inadequate for the subpopulation of non-obese women. The causes for this finding are yet to be elucidated; however, it could partially be explained by alterations in inflammatory \[[@pone.0194644.ref026]\] and oxidative stress \[[@pone.0194644.ref027]\] status induced by the shift from gynoid to android adiposity phenotype, further increasing the proportional risk for cardiovascular diseases in women in comparison with men. Our study is unable to elucidate causality relationships, because of its descriptive nature and cross-sectional design. Future prospective experimental or quasi experimental studies will be required to answer these pending questions.

In our study, we found that AO is associated with a higher deleterious impact on the frequency of CVRF in normal weight in comparison with overweight individuals in both sexes. Since WC was found to be directly correlated with BMI in both sexes and virtually all obese individuals had AO, we contend that WC determination is impractical for this type of subjects. In fact, NIH guidelines for the identification, evaluation and treatment of overweight and obesity in adults indicate that WC measurement is particularly useful in patients who are categorized as normal or overweight and that in individuals with BMI of ≥ 35 kg/m^2^, WC cutoff points lose incremental predictive power of the disease risk classification of BMI \[[@pone.0194644.ref011]\]. IDF guidelines state that in individuals with BMI 30 kg/m^2^, central obesity can be assumed, and WC does not need to be measured for practical clinical purposes \[[@pone.0194644.ref012]\].

The cross-sectional design of our study precludes the generation of definitive cutoff points for the definition of AO. However, we propose WC limits of 91 cm for men and 83 cm for women, as a suitable approximation for normal and overweight Hispanic individuals of Chile, since they allow the prediction of at least one CVRF. Importantly, our proposed cutoff points for non-obese individuals were calculated in a subsample with a mean BMI of 25.1 kg/m^2^, similar to the one reported in the Southeast Asian population used for establishing the IDF definition of AO \[[@pone.0194644.ref028]\] and proposed to be used in ethnic Central and South American population \[[@pone.0194644.ref029]\].

Overall, AO was present in an unexpectedly high proportion of overweight and normal weight people and it was associated with elevated frequency of cardiovascular risk factors and diseases. This finding stresses the importance of incorporating AO as a cardiometabolic risk estimator in normal and overweight individuals, in whom BMI clearly underestimates cardiovascular risk.

Considered together, our results support the use of WC at the clinical level to refine cardiovascular risk assessment. The low cost, feasibility and reproducibility of WC determination strongly advocates for its use \[[@pone.0194644.ref030]\]. Furthermore, since quantitative determination of intra-abdominal adiposity is unfeasible in most clinical settings, WC is an acceptable surrogate indicator \[[@pone.0194644.ref030]\]. Previous studies, using various designs and cutoff criteria, have reached similar conclusions across different populations worldwide \[[@pone.0194644.ref031]--[@pone.0194644.ref034]\].

Advances in the knowledge of adipose tissue biology have shed light on the mechanisms by which obesity and abnormal body fat distribution promotes atherosclerosis, dysglycemia, dyslipidemia and hypertension, including the ability of adipose tissue to modulate ectopic lipid accumulation in insulin responsive tissues \[[@pone.0194644.ref035]\], the secretion of protein and lipid endocrine mediators (adipokines) \[[@pone.0194644.ref036]\] and the modulation of tissue specific and general inflammatory status \[[@pone.0194644.ref037]\].

The main the limitations of our study are its cross-sectional design that prevents causation analysis, and the use of self-report as indicator of coronary and cerebrovascular disease.

In summary, we found that: 1) WC and BMI are directly correlated in both sexes and that the diagnosis of body adiposity, based on these indicators, is highly concordant for people with BMI \> 30 kg/m^2^. By contrast, important proportions of non-obese people (BMI 18.5--29.9 kg/m^2^) have AO, indicating that, in these people, the sole analysis of BMI may underestimate their cardiometabolic risk. 2) WC cutoff points of 91 cm for men and 83 cm for woman allow to discriminate at least one CVRF in normal and overweight adult Hispanic population of Chile.

We conclude that WC is a useful, inexpensive and easy to use tool for predicting CVRF and its use must be promoted in normal and overweight individuals in whom its incrementing predictive power to detect disease risk classification remains valid.

The authors thank Alba León Alvarez and Kabir Sadarangani Khianey for biostatistical advice.

AO

:   Abdominal obesity

WC

:   Waist circumference

CVRF

:   Cardiovascular risk factor

AUC-ROC

:   Area under curve of receiver operating characteristic

AMI

:   Acute myocardial infarction

ENS

:   National health survey of Chile

CI

:   Confidence interval

NIH

:   National institute of health USA

IDF

:   International diabetes federation

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
